Aortic Aneurysm Market Research Report - Forecast till 2030

Aortic Aneurysm Market Research Report: Information by Type (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm), Product (Stent Grafts, Catheters), Treatment (Endovascular Aneurysm Repair, Open Surgical Repair), End User Forecast till 2030

ID: MRFR/HC/6306-HCR | February 2023 | Region: Global | 90 Pages         

Aortic Aneurysm Market Speak to Analyst Request a Free Sample

Aortic Aneurysm Market

The Aortic Aneurysm Market is expected to reach USD 2848.51 Million by 2030 at 9.60% CAGR during the forecast period 2022-2030

Segmentation
By Type Abdominal Aortic Aneurysm (AAA) Thoracic Aortic Aneurysm (TAA)
By Product Stent-Grafts Catheters Others
By Treatment Endovascular Aneurysm Repair (EVAR) Open Surgical Repair (OSR)
By End Users Hospitals and Clinics Ambulatory Surgery Centers (ASCs) Others
Key Players
Companies Profiled   AbbVie Inc. (US)   Terumo Corporation (Japan)   R. Bard Inc. (US)   Medtronic Plc. (US)   Cardiatis S.A. (Belgium)   Lombard Medical Inc (UK)   Cardinal Health Inc. (US)   Others
Drivers
Market Driving Forces   increase the demand for the endovascular aortic aneurysm repair   rise to a high incidence of cardiovascular diseases
Request a Free Sample

Global Aortic Aneurysm Market Research (MRFR Insights)


The  aortic aneurysm market is projected to register a CAGR of 9.60% from 2022 to 2030. The increased frequency of atherosclerosis and the growing senior population are important market drivers. The  aortic aneurysm market size is expected to reach approximately USD 2848.51 billion by 2030. The increased frequency of atherosclerosis and the growing senior population are important market drivers. Furthermore, increased demand for less invasive procedures and favorable health reimbursement drive expansion. Increasing incidences of cardiovascular disease, quick adoption of sedentary lifestyles, and bad eating habits contribute to an increase in AA cases worldwide. The growing senior population adds to the patient pool. For instance, according to the United States Department of Health and Human Services, this population group in the United States numbered 54 million in 2019, accounting for over 16% of the total population. Furthermore, this figure is expected to rise to 80.8 million by 2040 and 94.7 million by 2060.


COVID-19 Impact Analysis


The deferral of elective surgery to control the spread of COVID-19 had a substantial impact on market growth. According to the National Vascular Registry, the number of AAA repairs in the United Kingdom fell by 78.1% in April 2021 compared to pre-pandemic levels. Companies producing AA repair devices have resumed full operations following the pandemic. This aided the market's recovery by early 2022. ​


Aortic Aneurysm Market Dynamics


The market for the  market is expected to grow substantially throughout the projected period. In most advanced countries, such as the US, the UK, and Japan, traditional surgical techniques are gradually being replaced with minimally invasive surgeries such as EVAR. Traditional surgery necessitates an incision to access interior body components for surgery, which necessitates high precision, intense concentration, and surgical expertise. However, the benefits of minimally invasive operations include less blood loss, minimal to no scarring, smaller incisions, shorter hospital stays with faster recovery times, and often better outcomes. As a result, the rising demand for minimally invasive EAVR procedures is boosting the market growth. In the next five years, the growing aging population will likely increase the overall number of AA repair procedures.


Market Drivers



  •   Technological developments and reimbursement for medical equipment will drive market expansion


Technological developments and reimbursement for medical equipment will drive market expansion. Furthermore, rising healthcare expenditure and rising R&D investment provide opportunities for market expansion. However, risks associated with surgical procedures and a stringent regulatory environment may stymie the abdominal aortic aneurysm industry. For instance, in the US, Medicare covers one abdominal aortic ultrasound for individuals who are at risk. Europe is predicted to account for a considerable market share throughout the projection period due to technological advancements and a high prevalence of atherosclerosis. The National Health Service (NHS) and the Food and Drug Administration (FDA) in the US are collaborating to lower the occurrence of aortic aneurysms.


Market Restraints


Lack of awareness and treatment availability is limiting the market's growth


Over the forecast period, the market's expansion would be hampered by a lack of knowledge and treatment availability. On the other hand, continuous technological advancements in endovascular surgical procedures are projected to drive market expansion in the future years.


market Opportunities:



  • Aneurysms are repaired using revolutionary 3D technologies


Using computerized prediction models based on the patient's pre-operative X-ray and anatomy, surgeons increasingly rely on dynamic 3D picture overlays of the human body. The models enable surgeons to eliminate iodine contrast and associated risk to the kidneys, reduce radiation exposure during surgery, and save time on the operating table. This development opens up new market opportunities.


Segment Overview


By Type Insights


The  aortic aneurysm market segmentation, by type, is abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). The integrated aortic aneurysm had more revenue share in the  aortic aneurysm market growth in 2021 due to the rising prevalence of the condition. An abdominal aortic aneurysm is more frequent in the lower abdomen, with most cases occurring either under the kidney or in the pararenal region of the lower abdomen. Abdominal aortic aneurysm affects around 2.5% of persons over the age of 65, according to a study published in the journal Circulation. Thoracic aortic aneurysm, on the other hand, occurs at a rate of 4.5% to 5.9% per 100,000 person-years. The highest growth of the thoracic aortic aneurysm (TAA) segment over the predicted period can be due to the low incidence of thoracic aortic aneurysm and the lack of modern devices for its endovascular management.


By Product Insights


The  aortic aneurysm market segmentation, by product, is stent-grafts, catheters, and others. In 2021, the stent-grafts segment generated the most revenue. During the forecast period, technological developments in stent-graft design will drive the segment's growth. For example, improved stent graft systems with integrated imaging and delivery catheters are being introduced. These devices can be used to treat aneurysms and other serious vascular injuries. The market is divided into two categories: stent grafts and catheters. The catheter segment is anticipated to grow at the highest rate during the forecast period.


By End User Insights


By end user, the market is segmented into hospitals & clinics, ambulatory surgery centers (ASCs), and others. The hospitals & clinics segment had the most revenue share in 2021 and is expected to register the fastest CAGR during the forecast period. Physicians and vascular surgeons regard hospitals as their preferred setting, particularly in underdeveloped nations. The extensive infrastructure in hospitals allows treating complex cases that cannot be handled in ASCs. Additionally, favorable reimbursement rules are projected to drive the industry.

Global Aortic Aneurysm Market Share by Region, 2021 (%)
Aortic Aneurysm Market Share by Region, 2021


 Aortic Aneurysm Market Overview, by Region


By Region, the  aortic aneurysm market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North American region accounted for the most extensive market share. Europe will exhibit the highest CAGR during the forecast period.


North America


In 2021, North America had the highest revenue share of the  market due to quick technical development, a move toward less invasive procedures, and an increase in the prevalence of AA. The Test Abdominal Aortic Aneurysms Very Efficiently (SAVE) Act, enacted by the US government in 2014, provides one free AAA screening for men who have smoked at least once in their lives and women who have a family history of the condition. Furthermore, hefty government reimbursements are assisting overall industry growth. In the US, for example, Medicare provides one abdominal aortic ultrasound for at-risk patients.


Europe


During the forecast period, Europe is expected to have the greatest CAGR. Due to technological improvements and the high prevalence of atherosclerosis, Europe is expected to account for a sizable proportion during the projection period. The National Health Service (NHS) and other international organizations aim to reduce the prevalence of aortic aneurysms. For example, the NHS in Europe's Public Health England screening program is a national population screening program that helps identify healthy people who may be at risk of developing an aortic aneurysm. As a result, early treatment and informed decisions are possible.
Aortic Aneurysm Market Competitive Landscape


The market includes tier-1, tier-2, and local players. The tier-1 and tier-2 players have  reach with diverse product portfolios. Companies such as AbbVie Inc. (US), Terumo Corporation (Japan), R. Bard Inc. (US), and Medtronic Plc. (US), Carditis S.A. (Belgium) dominates the  market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are concentrating on supporting research and development. Furthermore, they embrace strategic growth initiatives, such as development, product introduction, joint ventures, and partnerships, to strengthen their market position and capture an extensive customer base.


Prominent players in the  aortic aneurysm market research include AbbVie Inc. (US), Terumo Corporation (Japan), R. Bard Inc. (US), Medtronic Plc. (US), Cardiatis S.A. (Belgium), Lombard Medical Inc (UK), and Cardinal Health Inc. (US).


Scope of the  Aortic Aneurysm Market Segmatation


By Type Outlook



  • Abdominal Aortic Aneurysm (AAA)

  • Thoracic Aortic Aneurysm (TAA)


By Product Outlook



  • Stent-Grafts

  • Catheters

  • Others


By Treatment Outlook



  • Endovascular Aneurysm Repair (EVAR)

  • Open Surgical Repair (OSR)


By End User outlook



  • Hospitals & Clinics

  • Ambulatory Surgery Centers (ASCs)

  • Others


By Region Outlook



  • North America

    • US

    • Canada

    • Mexico



  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • India

    • Japan

    • Australia and New Zealand

    • Rest of Asia-Pacific



  • Rest of the World

    • South America

    • Middle East

    • Africa




Objectives of the Study


The objectives of the study are summarized in 5 stages. They are as mentioned below:



  • Aortic Aneurysm Market Forecast & Size:


To identify and estimate the market size for the  aortic aneurysm market report segmented by type, product, treatment, and end user by value (in US dollars). Also, to understand the consumption/ demand created by consumers in the  aortic aneurysm market forecast between 2022 and 2030.



  • Market Landscape and Trends:


To identify and infer the drivers, restraints, opportunities, and challenges in the  aortic aneurysm market growth



  • Market Influencing Factors:


To find out the factors which are affecting the  aortic aneurysm market size among consumers



  • Impact of COVID-19:


To identify and understand the various factors involved in the market affected by the pandemic



  • Company Profiling:


To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company in the past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.


Intended Audience



  • Producers

  • Hospitals, Healthcare key players

  • Governments, associations, and industrial bodies



Report Scope:

Report Attribute/Metric Details
   
 (CAGR)   9.60%CAGR (2022-2030)
Base year   2021
Forecast Period 2022-2030
Historical Data  2020
Forecast Units  Value (USD Billion)
Report Coverage  Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Type, Product, Treatment, and End-User
Geographies Covered North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
Key Vendors AbbVie Inc. (US), Terumo Corporation (Japan), R. Bard Inc. (US), Medtronic Plc. (US), Cardiatis S.A. (Belgium), Lombard Medical Inc (UK), and Cardinal Health Inc. (US)
Key Market Opportunities Aneurysms are repaired using revolutionary 3D technologies
Key Market Drivers Technological developments and reimbursement for medical equipment will drive market expansion.


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The  aortic aneurysm market forecast period is 2022 - 2030

The market is expected to register a CAGR of ~9.60% over the next 10 years, according to  aortic aneurysm market research.

Europe is expected to register the highest CAGR during 2022 - 2030

North America held the largest share in 2021

The market size is expected to be USD 2848.51 Million by 2030.

AbbVie Inc. (US), Terumo Corporation (Japan), R. Bard Inc. (US), Medtronic Plc. (US), Cardiatis S.A. (Belgium), Lombard Medical Inc (UK), and Cardinal Health Inc. (US) are the major companies operating in the market.